SEARCH WITHIN CONTENT
Citation Information : Polish Journal of Microbiology. Volume 66, Issue 4, Pages 533-536, DOI: https://doi.org/10.5604/01.3001.0010.7092
License : (CC BY-NC-ND 4.0)
Received Date : 21-November-2016 / Accepted: 12-January-2017 / Published Online: 04-December-2017
The authors studied the in vitro antibacterial activity of the photo-activated porphyrin meso-tri(N-methyl-pyridyl), mono(N-tetradecyl-pyridyl)porphine (C14) against four multidrug-resistant bacteria: Staphylococcus aureus, Enterococcus faecalis (Gram-positive), Escherichia coli, Pseudomonas aeruginosa (Gram-negative). Using 10 μg/ml of porphyrin and 60 sec irradiation we observed the remarkable susceptibility of S. aureus and E. faecalis to treatment while, under the same conditions, E. coli and P. aeruginosa showed very low susceptibility.In a later stage, suspensions of Gram-negative bacteria were processed with EDTA before photo-activation, obtaining a significant decrease in viable counts. In view of the results, if the combination of low porphyrin concentrations and short irradiation times will be effectivein vivo also, this approach could be a possible alternative to antibiotics, in particular against localized infections due to multidrug-resistant microorganisms.
Dai T., Y. Huang and M. Hamblin. 2009. Photodynamic therapy for localized infections-State of the art. Photodiagnosis Photodyn. Ther. 6: 170–188
Dantes R., Y. Mu, R. Belflower, D. Aragon, G. Dumyati, L.H. Harrison, F.C. Lessa, R. Lynfield J., Nadle, S. Petit et al. 2013. National burden of invasive methicillin-resistant Staphylococcus aureus infec-tions, United States. JAMA Intern. Med. 173: 1970–1978.
de Niederhausern S., M. Bondi, P. Messi, R. Iseppi, C. Sabia,G. Manicardi and I. Anacarso. 2011. Vancomycin-resistance transferability from VanA enterococci to Staphylococcus aureus. Curr. Microbiol. 62: 1363–1367.
de Niederhausern S., C. Sabia, P. Messi, E. Guerrieri, G. Manicardi and M. Bondi. 2007. VanA-type vancomycin-resistant enterococci in equine and swine rectal swabs and in human clinical samples. Curr. Microbiol. 55: 240–246.
Huang L., T. Dai and M.R. Hamblin. 2010. Antimicrobial photodynamic inactivation and photodynamic therapy for infections. Methods Mol. Biol. 635: 155–173.
Jori G., C. Fabris, M. Soncin, S. Ferro, O. Coppellotti, D. Dei,L. Fantetti, G. Chiti and G. Roncucci. 2006. Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applications. Lasers Surg. Med. 38: 468–481.
Lazzeri D., M. Rovera, L. Pascual and E.N. Durantini. 2004. Photodynamic studies and photoinactivation of Escherichia coli using meso-substituted cationic porphyrin derivatives with asymmetric charge distribution. J. Photochem. Photobiol. 80: 286–293.
Magaraggia M., F. Faccenda, A. Gandolfi and G. Jori. 2006. Treatment of microbiologically polluted aquaculture waters by a novel photochemical technique of potentially low environmental impact. J. Environ. Monitor 8: 923–931.
Merchat M., G. Bertolini, P. Giacomini, A. Villanueva and G. Jori. 1996a. Meso-substituted cationic porphyrins as efficient photosensitizers of Gram-positive and Gram-negative bacteria J. Photochem. Photobiol. 32: 153–157.
Merchat M., J.D. Spikes, G. Bertoloni and G. Jori. 1996b. Studies on the mechanism of bacteria photosensitization by meso-substituted cationic porphyrins. J. Photochem. Photobiol. 35: 149–153.
National Nosocomial Infections Surveillance System. 2004. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control. 32: 470–485.
Reddi E., M. Ceccon, G. Valduga, G. Jori, J.C. Bommer, F. Elisei,L. Latterini and U. Mazzucato. 2002. Photophysical propertiesand antibacterial activity of meso-substituted cationic porphyrins. Photochem. Photobiol. 75: 462–470.
Shaikh S., J. Fatima, S. Shakil, S.M.D. Rizvi and M.A. Kamal. 2015. Antibiotic resistance and extended spectrum beta-lactamases: types, epidemiology and treatment. Saudi J. Biol. Sci. 22: 90–101.
Sievert D. M., M.L. Boulton, G. Stoltman, D. Johnson, M.G. Stobierski, W. Brown, W. Hafeez and T. Lundstrom. 2002. Staphylococcus aureus resistant to vancomycin-United States. MMWR Morb. Mortal. Wkly. Rep. 51: 565–567.
Tavares A.1., C.M. Carvalho, M.A. Faustino, M.G. Neves,J.P. Tomé, A.C. Tomé, J.A. Cavaleiro, A. Cunha, N.C. Gomes,E. Alves and A. Almeida. 2010. Antimicrobial photodynamic therapy: study of bacterial recovery viability and potential development of resistance after treatment. Mar. Drugs. 8: 91–105.
Wainwright M. and K.B. Crossley. 2004. Photosensitizing agents circumventing resistance and breaking down biofilms: a review. Int. Biodeterior. Biodegrad. 53: 119–126.